Total planned funding: $2,908,356,570
Clear active filters
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
| South Africa | $365,769,557 |
| Kenya | $349,668,060 |
| Uganda | $318,333,123 |
| Nigeria | $274,852,275 |
| Zambia | $271,467,084 |
| Tanzania | $235,464,102 |
| Ethiopia | $206,785,109 |
| Mozambique | $153,351,091 |
| Rwanda | $127,324,304 |
| Haiti | $107,391,687 |
| Botswana | $106,793,737 |
| Namibia | $99,807,386 |
| Côte d'Ivoire | $87,467,121 |
| Vietnam | $61,644,000 |
| Guyana | $41,119,434 |
| India | $29,585,000 |
| Zimbabwe | $21,957,000 |
| Cambodia | $19,252,000 |
| Malawi | $16,369,500 |
| Russia | $13,955,000 |
Organizational Types
| Unknown | $874,449,195 |
| NGO | $741,549,242 |
| University | $306,420,653 |
| Private Contractor | $290,302,821 |
| Own Agency | $246,351,013 |
| FBO | $194,362,626 |
| Host Country Government Agency | $163,228,431 |
| Implementing Agency | $52,618,294 |
| Other USG Agency | $21,260,004 |
| Parastatal | $11,711,370 |
| Multi-lateral Agency | $6,102,921 |
Program Areas
| Treatment | $1,046,344,233 |
| Prevention | $638,349,434 |
| Care | $476,906,698 |
| Governance and Systems | $380,100,248 |
| Testing | $200,183,552 |
| Management and Operations | $166,697,405 |
Budget Codes
| HTXS: Treatment: Adult Treatment | $611,065,434 |
| HTXD: Treatment: ARV Drugs | $435,278,799 |
| HBHC: Care: Adult Care and Support | $228,072,557 |
| HVCT: Testing: HIV Testing and Counseling | $200,183,552 |
| HKID: Care: Orphans and Vulnerable Children | $189,237,123 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $189,124,048 |
| HVMS: Management and Operations | $166,697,405 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $154,344,189 |
| HVSI: Strategic Information | $145,056,857 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $142,697,320 |
| HLAB: Laboratory Infrastructure | $130,675,642 |
| OHSS: Health Systems Strengthening | $104,367,749 |
| HMBL: Biomedical Prevention: Blood Safety | $84,398,302 |
| HMIN: Biomedical Prevention: Injection Safety | $67,785,575 |
| HVTB: Care: TB/HIV | $59,597,018 |